Combination Therapy of Angiotensin II Receptor Blocker and Calcium Channel Blocker Exerts Pleiotropic Therapeutic Effects in Addition to Blood Pressure Lowering: Amlodipine and Candesartan Trial in Yokohama (ACTY)

By Maeda Akinobu   Tamura Kouichi   Kanaoka Tomohiko   Ohsawa Masato   Haku Sona   Azushima Kengo   Dejima Toru   Wakui Hiromichi   Yanagi Mai   Okano Yasuko   Fujikawa Tetsuya   Toya Yoshiyuki   Mizushima Shunsaku   Tochikubo Osamu   Umemura Satoshi  

Clinical and Experimental Hypertension, Vol. 34, Iss. 4, 2012-07 ,pp. : 249-257

Informa Healthcare

Access to resources Recommend Favorite

Angiotensin Receptor Blockers and Target-Organ Protection Beyond Blood Pressure Control

By Riccardo Sarzani   Paolo Dessì-Fulgheri   Alessandro Rappelli  

High Blood Pressure & Cardiovascular Prevention, Vol. 11, Iss. 2, 2004-01 ,pp. : 65-73

Adis International

Access to resources Recommend Favorite

Ambulatory Blood Pressure Monitoring to Assess the Comparative Efficacy and Duration of Action of a Novel New Angiotensin II Receptor Blocker - Telmisartan

By Neutel Joel M.  

Blood Pressure, Vol. 10, Iss. 1, 2001-02 ,pp. : 27-32

Informa Healthcare

Access to resources Recommend Favorite

Blood Pressure-Lowering Effects of Angiotensin Receptor Antagonist Monotherapy and in Combination with Other Anti-Hypertensive Drugs in Primary Care Settings in Japan

By Kushiro Toshio   Saito Ikuo   Hirata Koji   Ishikawa Mayumi   Yamashita Tomonari   Matsushita Yasuyuki   Sagawa Kei   Hiramatsu Katsutoshi   Komiya Masahiro  

Clinical and Experimental Hypertension, Vol. 31, Iss. 2, 2009-04 ,pp. : 127-141

Informa Healthcare

Access to resources Recommend Favorite

Residual Cardiovascular Risk in Individuals on Blood Pressure–Lowering Treatment

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 11, 2015-11 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite